Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous useInitial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
LYUMJEV® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
- generic_name
- insulin lispro-aabc
- product_names
- Insulin lispro-aabc
- ndc
- 50090-7433, 0002-7728, 50090-7433-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en